Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 04-2015 | 01-2015 | 10-2014 | 07-2014 | 04-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,727 | -7,820 | -3,729 | -9,977 | -6,808 |
| Depreciation Amortization | 2,797 | 1,873 | 938 | 3,971 | 3,015 |
| Income taxes - deferred | -71 | -48 | -24 | -18 | -65 |
| Accounts receivable | -940 | -524 | -482 | -3,224 | -2,482 |
| Accounts payable and accrued liabilities | -957 | -1,423 | -1,157 | -226 | -1,063 |
| Other Working Capital | -2,859 | -2,688 | -1,001 | 338 | -1,387 |
| Other Operating Activity | 4,587 | 4,158 | 2,700 | 7,439 | 6,056 |
| Operating Cash Flow | $-8,170 | $-6,472 | $-2,755 | $-1,697 | $-2,734 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,168 | -653 | -264 | -838 | -570 |
| Other Investing Activity | -1 | 0 | 5 | 5 | 46 |
| Investing Cash Flow | $-1,169 | $-653 | $-259 | $-833 | $-524 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 65,389 | 43,362 | 22,360 | 78,814 | 56,826 |
| Debt Repayment | -316 | -230 | -115 | -374 | -280 |
| Common Stock Issued | 6,687 | 5,341 | 2,322 | 11,542 | 9,455 |
| Other Financing Activity | -65,389 | -43,362 | -22,360 | -79,065 | -57,077 |
| Financing Cash Flow | $6,371 | $5,111 | $2,207 | $10,917 | $8,924 |
| Exchange Rate Effect | -112 | -95 | -57 | 61 | 131 |
| Beginning Cash Position | 17,455 | 17,455 | 17,455 | 9,007 | 9,007 |
| End Cash Position | 14,375 | 15,346 | 16,591 | 17,455 | 14,804 |
| Net Cash Flow | $-3,080 | $-2,109 | $-864 | $8,448 | $5,797 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,170 | -6,472 | -2,755 | -1,697 | -2,734 |
| Capital Expenditure | -1,168 | -653 | -264 | -838 | -570 |
| Free Cash Flow | -9,338 | -7,125 | -3,019 | -2,535 | -3,304 |